H.E.L Group appoints Professor Yih-Shing Duh as Chief Scientific Advisor
Expert in battery testing further strengthens H.E.L’s expertise in thermal safety Professor Duh wi
Quantifying public and private investment in European biopharmaceutical research and development
This peer-reviewed paper was published in the June 2024 issue of Health Affairs Scholar.
500 patients benefit from Trust’s life-saving robots
Addenbrooke’s three surgical robots have helped specialists carry out nearly 540 life-saving or life altering operations in the last 12 months.
Guardtech Summer Update: Group looking strong on all construction fronts
Suffolk-based cleanroom installation experts undertaking complex projects both at home and overseas as the Summer season heats up.
Thousands of high-risk cancer gene variants identified
Over 5,000 genetic variants that enable certain cancers to thrive have been identified by scientists, along with a potential therapeutic target to treat or even prevent these cancers from developing.
Western superbugs do not dominate in Pakistan
Certain antibiotic-resistant strains of bacteria endemic to the UK, Norway and the USA have not taken hold in Pakistan despite the widespread use of antibiotics in this region.
Cutting-edge genomic test can improve care of children with cancer
Whole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care.
Optibrium demonstrates accelerated lead optimisation in complex agrochemical development
Optibrium’s QuanSA 3D-QSAR method uses an active learning approach to successfully and more efficiently identify a mimic of a macrocyclic natural product
Cellular Origins acquires ACTIA Platform IP to enhance automated cell therapy manufacturing
Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabilities of Constellation platform
Nxera Pharma receives US$10 million from AbbVie as collaboration targeting neurological diseases achieves first R&D milestone
Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co.
Bio-Rad launches ChemiDoc Go Imaging System
Compact system uses CMOS Digital Imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology
Pulmonary fibrosis: challenges in diagnosis, treatment and management
Pulmonary fibrosis (PF) is a progressive lung disease characterised by fibrosis or scarring of the lung tissue.
Are you going through a career slump?
If you were to score out of 10 how excited and motivated you feel about your work (and career) what number would you give it? If you score it 8, 9 or 10, give yourself a big pat on the back - you are really fortunate! If you give it a 6 -7 out of 10, there is room for improvement... Anything less than 6 needs serious action!
Brave crash patient Emily is focus of final episode
The eighth and final episode of The Face Doctors filmed at Addenbrooke’s Hospital will air on Really at 9pm on Wednesday (3 July), with the full series available to stream on discovery+.
Transforming Healthcare Podcast: bridging industry and academia for innovation
In this episode host Dr.
Bio-Rad launches Celselect Slides 2.0 to advance rare cell and circulating tumor cell enrichment for cancer research
New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream Applications
CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team
Key appointment to support continued UK and US team expansionCambridge, UK, 27:
ELRIG UK and The Protein Society partner to advance protein sciences in drug discovery
Cambridge, UK and Los Angeles, US: The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, has partnered with The
ASCO 2024 review: The benefits and barriers of biomarkers in oncology
Once again, Chicago saw the gathering of oncologists to discuss the latest developments in cancer. This year, considerable emphasis was placed on antibody-drug conjugates (ADCs), with several sessions dedicated exclusively to this technology.
Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes
Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards
Primerdesign launches real-time PCR workflow for onsite detection of Norovirus in Oysters
genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue Onsit
Bio-Rad extends range of anti-biotherapeutic antibodies to accelerate antibody drug development
Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials
mRNA influenza vaccines – VacZine Analytics forecast a third of global market value in 2030
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the seasonal influenza vaccine market including mRNA products (monovalent and combinations)
Skull surgery offers hope for horror fall patient
The amazing story of a young man who fell from a hotel balcony causing a massive head injury is told in the seventh episode of The Face Doctors at 9pm this Wednesday (26 June), and available to stream via discovery+.
Immune response study explains why some people don't get COVID-19
Scientists have discovered novel immune responses that help explain how some individuals avoid getting COVID-19.